ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Kyowa Kirin Co., Ltd. clinical trials

Also known as Kyowa Hakko Kirin.

Part of Kirin Holdings Company, Limited, which holds 55.17% as of 2026-03-19. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 232 studies whose lead sponsor is Kyowa Kirin Co., Ltd. or one of 7 companies grouped under it. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 9 registry names, not the registry’s. See them and correct one ↓

Compare Kyowa Kirin with BioMarin Pharmaceutical and Johnson & Johnson →

Pipeline: 15 programs

Each counted once: 15 with a study Kyowa Kirin Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Kyowa Kirin Co., Ltd.’s own registered studies; Kyowa Kirin Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Kyowa Kirin Co., Ltd.’s studies test, most open studies first — 32 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 32; every drug is on its own page, and each page lists its sponsors.

Coming up

2 of Kyowa Kirin Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 232 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now125%
  • Under way, not recruiting104%
  • Completed18278%
  • Stopped early2410%Terminated 21 · Withdrawn 3
  • Status unknown or other42%Status unknown 2 · No longer available 1 · Available 1

Phase

  • Phase 180
  • Phase 275
  • Phase 368
  • Phase 47

Where

  • Japan121
  • United States66
  • United Kingdom27
  • Korea, Republic of22
  • Italy17
  • France15

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 2219
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 326

By the year each study started; 24 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    159 studies
  • Kyowa Kirin, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies
  • Kyowa Kirin Pharmaceutical Development Ltd
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • Kyowa Kirin Korea Co., Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Archimedes Development Ltd
    Acquired — became part of Kyowa Kirin Co., Ltd., Aug 5, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Orchard Therapeutics
    Acquired — became part of Kyowa Kirin Co., Ltd., Jan 24, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Kyowa Hakko Bio Co., Ltd.
    Divested — left Kyowa Kirin Co., Ltd., Apr 24, 2019 · 1 more first submitted after it left, not counted · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Kyowa Kirin China Pharmaceutical Co., Ltd.
    Divested — left Kyowa Kirin Co., Ltd., Sep 14, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Kyowa Kirin Farmacéutica S.L.U.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Related but not counted here: Fujifilm Kyowa Kirin Biologics Co., Ltd. (affiliate).

Focus areas

Conditions Kyowa Kirin Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 232. Browse all 232 →